5:04 pm Sangamo BioSci: First-in-man study of genome editing using Sangamo’s ZFN technology published in NEJM
View todays social media effects on SGMO
View the latest stocks trending across Twitter. Click to view dashboard
View todays social media effects on SGMO
View the latest stocks trending across Twitter. Click to view dashboard